187 related articles for article (PubMed ID: 21948906)
1. Amisulpride augmentation of clozapine in refractory schizophrenia.
Chiu HW; Ku YC; Li TC; Huang HT
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
[No Abstract] [Full Text] [Related]
2. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
Kämpf P; Agelink MW; Naber D
Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
[No Abstract] [Full Text] [Related]
3. Clozapine augmentation with amisulpride.
Porcelli S; Serretti A; Bianchini O
J Psychiatry Neurosci; 2014 Nov; 39(6):E38-9. PubMed ID: 25340724
[No Abstract] [Full Text] [Related]
4. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
George S; Cowan C
Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440
[No Abstract] [Full Text] [Related]
5. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
Dervaux A; Cazali J
J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
[No Abstract] [Full Text] [Related]
6. Clozapine with amisulpride for refractory schizophrenia.
Agelink MW; Kavuk I; Ak I
Am J Psychiatry; 2004 May; 161(5):924-5. PubMed ID: 15121665
[No Abstract] [Full Text] [Related]
7. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
[TBL] [Abstract][Full Text] [Related]
8. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
Munro J; Matthiasson P; Osborne S; Travis M; Purcell S; Cobb AM; Launer M; Beer MD; Kerwin R
Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
Hotham JE; Simpson PJ; Brooman-White RS; Basu A; Ross CC; Humphreys SA; Larkin F; Gupta N; Das M
CNS Spectr; 2014 Oct; 19(5):403-10. PubMed ID: 24284256
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
Kreinin A; Novitski D; Weizman A
Int Clin Psychopharmacol; 2006 Mar; 21(2):99-103. PubMed ID: 16421461
[TBL] [Abstract][Full Text] [Related]
11. Clozapine augmented with amisulpride in 3 cases of treatment-resistant early- and very early-onset schizophrenia.
Tufan AE; Yalug I
J Clin Psychopharmacol; 2013 Aug; 33(4):572-4. PubMed ID: 23764685
[No Abstract] [Full Text] [Related]
12. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
Lang UE; Willbring M; von Golitschek R; Schmeisser A; Matschke K; Malte Tugtekin S
J Psychopharmacol; 2008 Jul; 22(5):576-80. PubMed ID: 18308817
[TBL] [Abstract][Full Text] [Related]
13. Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.
Pehlivanidis A; Spyropoulou AC; Tourkantonis A; Papadimitriou GN
Clin Neuropharmacol; 2010 May; 33(3):168. PubMed ID: 20502137
[No Abstract] [Full Text] [Related]
14. Adjunctive ondansetron in schizophrenia--A pilot study.
Hema T; Maran S; Subhashini G
Asian J Psychiatr; 2016 Feb; 19():66-7. PubMed ID: 26957341
[No Abstract] [Full Text] [Related]
15. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.
Englisch S; Enning F; Grosshans M; Marquardt L; Waltereit R; Zink M
Clin Neuropharmacol; 2010; 33(5):227-9. PubMed ID: 20838213
[TBL] [Abstract][Full Text] [Related]
16. Amisulpride treatment for clozapine-induced sialorrhea.
Praharaj SK; Sarkar S; Sinha VK
J Clin Psychopharmacol; 2009 Apr; 29(2):189-90. PubMed ID: 19512987
[No Abstract] [Full Text] [Related]
17. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study.
Shiloh R; Zemishlany Z; Aizenberg D; Radwan M; Schwartz B; Dorfman-Etrog P; Modai I; Khaikin M; Weizman A
Br J Psychiatry; 1997 Dec; 171():569-73. PubMed ID: 9519099
[TBL] [Abstract][Full Text] [Related]
18. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
[TBL] [Abstract][Full Text] [Related]
19. Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
Rettenbacher MA; Hummer M; Hofer A; Baumgartner S; Ebenbichler C; Edlinger M; Kemmler G; Lechleitner M; Wolfgang Fleischhacker W
J Psychopharmacol; 2007 Jun; 21(4):400-4. PubMed ID: 17050656
[TBL] [Abstract][Full Text] [Related]
20. Tardive dystonia associated with low-dose of amisulpride: a case report.
Sevincok L; Balci V; Akyildiz U
J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
